Latest & greatest articles for babies

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on babies or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on babies and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for babies

21. Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants

Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia in preterm infants Historically, postnatal corticosteroids have been used to prevent and treat bronchopulmonary dysplasia (BPD), a significant cause of morbidity and mortality in preterm infants. Administering dexamethasone to prevent BPD in the first 7 days post-birth has been associated with increasing risk for cerebral palsy, while early inhaled corticosteroids appear to be associated with an increased risk of mortality (...) . Neither medication is presently recommended to prevent BPD. New evidence suggests that prophylactic hydrocortisone, when initiated in the first 48 h post-birth, at a physiological dose, and in the absence of indomethacin, improves survival without BPD, with no adverse neurodevelopmental effects at 2 years. This therapy may be considered by clinicians for infants at highest risk for BPD. Routine dexamethasone therapy for all ventilator-dependent infants is not recommended, but after the first week

2020 Canadian Paediatric Society

22. Randomized Study of Delayed Cord Clamping of 30 to 60 Seconds in the Larger Infant Born Preterm

Randomized Study of Delayed Cord Clamping of 30 to 60 Seconds in the Larger Infant Born Preterm Randomized Study of Delayed Cord Clamping of 30 to 60 Seconds in the Larger Infant Born Preterm - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information (...) Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Case Reports J Pediatr Actions . 2020 Jul 7;S0022-3476(20)30562-X. doi: 10.1016/j.jpeds.2020.04.058. Online ahead of print. Randomized Study of Delayed Cord Clamping of 30 to 60 Seconds in the Larger Infant Born Preterm , , , Affiliations Expand

2020 EvidenceUpdates

23. Transmitted Home Oximetry and Duration of Home Oxygen in Premature Infants

Transmitted Home Oximetry and Duration of Home Oxygen in Premature Infants Transmitted Home Oximetry and Duration of Home Oxygen in Premature Infants - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC: . Get the latest research from (...) Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Pediatrics Actions . 2020 Aug;146(2):e20200079. doi: 10.1542/peds.2020-0079. Epub 2020 Jul 14. Transmitted Home Oximetry and Duration of Home Oxygen in Premature Infants , , , , , , , , , , , , Affiliations Expand Affiliations 1 Divisions of Neonatology and lawrence.rhein

2020 EvidenceUpdates

24. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. Full Text available with Trip Pro

Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infection in infants, and a need exists for prevention of RSV in healthy infants. Nirsevimab is a monoclonal antibody with an extended half-life that is being developed to protect infants for an entire RSV season with a single intramuscular dose.In this trial conducted in both northern and southern hemispheres, we evaluated nirsevimab (...) for the prevention of RSV-associated lower respiratory tract infection in healthy infants who had been born preterm (29 weeks 0 days to 34 weeks 6 days of gestation). We randomly assigned the infants in a 2:1 ratio to receive nirsevimab, at a dose of 50 mg in a single intramuscular injection, or placebo at the start of an RSV season. The primary end point was medically attended RSV-associated lower respiratory tract infection through 150 days after administration of the dose. The secondary efficacy end point

2020 NEJM

25. Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. Full Text available with Trip Pro

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants. Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory tract infection in infants, with the most severe cases concentrated among younger infants.Healthy pregnant women, at 28 weeks 0 days through 36 weeks 0 days of gestation, with an expected delivery date near the start of the RSV season, were randomly assigned in an overall ratio of approximately 2:1 to receive a single intramuscular (...) dose of RSV fusion (F) protein nanoparticle vaccine or placebo. Infants were followed for 180 days to assess outcomes related to lower respiratory tract infection and for 364 days to assess safety. The primary end point was RSV-associated, medically significant lower respiratory tract infection up to 90 days of life, and the primary analysis of vaccine efficacy against the primary end point was performed in the per-protocol population of infants (prespecified criterion for success, lower bound

2020 NEJM

26. Early fortification of human milk versus late fortification to promote growth in preterm infants. (Abstract)

Early fortification of human milk versus late fortification to promote growth in preterm infants. Uncertainty exists about the optimal point at which multi-component fortifier should be added to human milk for promoting growth in preterm infants. The most common practice is to start fortification when the infant's daily enteral feed volume reaches 100 mL/kg body weight. Another approach is to commence fortification earlier, in some cases as early as the first enteral feed. Early fortification (...) of human milk could increase nutrient intake and growth rates but may increase the risk of feed intolerance and necrotising enterocolitis (NEC).To assess effects on growth and safety of early fortification of human milk versus late fortification in preterm infants To assess whether effects vary based upon gestational age (≤ 27 weeks; 28 to 31 weeks; ≥ 32 weeks), birth weight (< 1000 g; 1000 to 1499 g; ≥ 1500 g), small or appropriate for gestational age, or type of fortifier (bovine milk-based human

2020 Cochrane

27. Education of family members to support weaning to solids and nutrition in later infancy in term-born infants. (Abstract)

Education of family members to support weaning to solids and nutrition in later infancy in term-born infants. Education of family members about infant weaning practices could affect nutrition, growth, and development of children in different settings across the world.To compare effects of family nutrition educational interventions for infant weaning with conventional management on growth and neurodevelopment in childhood.We used the standard strategy of Cochrane Neonatal to search the Cochrane (...) randomised controlled trials that examined effects of nutrition education for weaning practices delivered to families of infants born at term compared to conventional management (standard care in the population) up to one year of age.Two review authors independently identified eligible trial reports from the literature search and performed data extraction and quality assessments for each included trial. We synthesised effect estimates using risk ratios (RRs), risk differences (RDs), and mean differences

2020 Cochrane

28. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial. (Abstract)

Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial. Maternal docosahexaenoic acid (DHA) supplementation may prevent bronchopulmonary dysplasia, but evidence remains inconclusive.To determine whether maternal DHA supplementation during the neonatal period improves bronchopulmonary dysplasia-free survival in breastfed infants born before 29 weeks of gestation.Superiority, placebo-controlled (...) randomized clinical trial at 16 Canadian neonatal intensive care units (June 2015-April 2018 with last infant follow-up in July 2018). Lactating women who delivered before 29 weeks of gestation were enrolled within 72 hours of delivery. The trial intended to enroll 800 mothers, but was stopped earlier.There were 232 mothers (273 infants) assigned to oral capsules providing 1.2 g/d of DHA from randomization to 36 weeks' postmenstrual age and 229 mothers (255 infants) assigned to placebo capsules.The

2020 JAMA

29. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. (Abstract)

versus non-digital TCC The effect is unknown due to lack of studies reporting this comparison. TCCMD versus digital non-targeted communication TCCMD may increase infant ARV/prevention of mother-to-child transmission treatment adherence (RR 1.26, 95% CI 1.07 to 1.48; low-certainty evidence). The effect on other outcomes is unknown due to lack of studies. Parents of children aged less than five years No studies reported on correct treatment, nutritional, or health outcomes. TCCMD versus standard care (...) Targeted client communication via mobile devices for improving maternal, neonatal, and child health. The global burden of poor maternal, neonatal, and child health (MNCH) accounts for more than a quarter of healthy years of life lost worldwide. Targeted client communication (TCC) via mobile devices (MD) (TCCMD) may be a useful strategy to improve MNCH.To assess the effects of TCC via MD on health behaviour, service use, health, and well-being for MNCH.In July/August 2017, we searched five

2020 Cochrane

30. Head midline position for preventing the occurrence or extension of germinal matrix-intraventricular haemorrhage in preterm infants. (Abstract)

Head midline position for preventing the occurrence or extension of germinal matrix-intraventricular haemorrhage in preterm infants. Head position during care may affect cerebral haemodynamics and contribute to the development of germinal matrix-intraventricular haemorrhage (GM-IVH) in very preterm infants. Turning the head toward one side may occlude jugular venous drainage while increasing intracranial pressure and cerebral blood volume. It is suggested that cerebral venous pressure (...) is reduced and hydrostatic brain drainage improved if the infant is cared for in the supine 'head midline' position.To assess whether head midline position is more effective than other head positions for preventing (or preventing extension) of GM-IVH in very preterm infants (< 32 weeks' gestation at birth).We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 9), MEDLINE via PubMed (1966 to 12 September 2019), Embase

2020 Cochrane

31. Tummy Time and Infant Health Outcomes: A Systematic Review

Tummy Time and Infant Health Outcomes: A Systematic Review Tummy Time and Infant Health Outcomes: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show account info Close Account Logged in as: username (My (...) Actions . 2020 Jun;145(6):e20192168. doi: 10.1542/peds.2019-2168. Epub 2020 May 5. Tummy Time and Infant Health Outcomes: A Systematic Review , , , Affiliations Expand Affiliations 1 Early Start, Faculty of Social Sciences, University of Wollongong and Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia llh966@uowmail.edu.au. 2 Early Start, Faculty of Social Sciences, University of Wollongong and Illawarra Health and Medical Research Institute, Wollongong, New South

2020 EvidenceUpdates

32. Guide for Completion of the Low-Risk Infant Transport Patient Care Flow Sheet

Record infant skin temperature. Circle method used to determine infant skin temperature, axilla or servo. If the method changes during the transport, please indicate this, and state reason why, in the Narrative Nursing Notes. Vital signs Heart rate Record the baby’s heart rate in beats per minutes. SpO 2 Record the baby’s pulse oximeter oxygen saturation percentage. Respiratory Rate Record the baby’s respiratory rate in breaths per minute. Oxygenation Use legend to record O 2 administration route. O (...) Guide for Completion of the Low-Risk Infant Transport Patient Care Flow Sheet BC Low-Risk Infant Transport Patient Care Flow Sheet (PSBC 1996) Guide for Completion June 2020BC Low-Risk Infant Transport Patient Care Flow Sheet (PSBC 1996) 2 © 2020 Perinatal Services BC Suggested Citation: Perinatal Services BC. (June 2020). BC Low-Risk Infant Transport Patient Care Flow Sheet: A Guide for Completion. Vancouver, BC. All rights reserved. No part of this publication may be reproduced for commercial

2020 British Columbia Perinatal Health Program

33. Low-Risk Infant Ground Transport in the Care of a Registered Nurse: Practice Resource

information for the baby’s parents and family physician $ $ Completed discharge summary $ $ Completed All About Me document (see Appendix 3) • Required infant transport supplies and equipment are available, checked and in working order • Telephonic Handover / Report between sending and receiving unit RN • Arrange for return options for RN and transport equipment as return is not guaranteed with BSAC carPerinatal Services BC Low-Risk Infant Ground Transport in the Care of a Registered Nurse 9 Roles (...) . Please ask the nurse or social worker at St Paul’s Hospital for this information. The number of people welcomed at the bedside will be determined with the parents to meet the needs of the infant, family and NICU. All visitors must be accompanied by a parent of the baby. • The baby’s brothers and sisters are the only children allowed into the nursery. • Visitors are not to come into the NICU if they have a fever, or symptoms of an acute illness. These include cold, cough, flu, diarrhea, vomiting

2020 British Columbia Perinatal Health Program

34. Saving babies’ lives care bundle Version 2: COVID-19 information

Saving babies’ lives care bundle Version 2: COVID-19 information NHS England » Saving babies’ lives care bundle Version 2: COVID-19 information Cookies on the NHS England and NHS Improvement website We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie (...) to save your choice. You can before you choose. Change my preferences I'm OK with analytics cookies Search Search Menu . If you are a member of the public looking for health advice, go to the . And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the . Saving babies’ lives care bundle Version 2: COVID-19 information Document first published: 3 April 2020 Page updated: 25 June 2020 Topic: Publication type: Information on CO monitoring

2020 NHS England

35. Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National (...) of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Pediatr Actions . 2020 Jun 15;e201447. doi: 10.1001/jamapediatrics.2020.1447. Online ahead of print. Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial , , , , Affiliations Expand Affiliations 1 Samsung Medical Center, Department of Pediatrics, Sungkyunkwan University School of Medicine, Seoul, Korea. 2 Statistics and Data Center

2020 EvidenceUpdates

36. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial

Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced (...) management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation BJOG Actions . 2020 Apr 1. doi: 10.1111/1471-0528.16239. Online ahead of print. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial , , , , , , , , , , , Collaborators, Affiliations Expand Collaborators MASP research group

2020 EvidenceUpdates

37. Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial Full Text available with Trip Pro

Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Pediatr Actions . 2020 Apr 27;174(7):1-8. doi: 10.1001/jamapediatrics.2020.0559. Online ahead of print. Cycled Phototherapy Dose-Finding Study for Extremely Low-Birth-Weight Infants: A Randomized Clinical Trial , , , , , , , , , , , Affiliations Expand Affiliations 1 McGovern Medical School, University of Texas, Houston. 2 Birmingham School of Medicine, University of Alabama, Birmingham. 3 Stanford University School

2020 EvidenceUpdates

38. Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia. (Abstract)

Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia. Phototherapy is a well-established effective therapy for treating babies with significant neonatal jaundice. Studies have shown that increasing light intensity will increase its efficiency. A potentially inexpensive and easy way of increasing the intensity of light on the body of the infant may be to hang reflective materials from the sides of phototherapy units.To assess the effects (...) . We also searched clinical trials databases and the reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials.We included randomised and quasi-randomised controlled trials if the participants, who were term or preterm infants, received phototherapy with curtains made of reflective materials of any type in the treatment arm, and if those in the comparison arm received similar phototherapy without curtains or other intensified phototherapy, such as a double

2020 Cochrane

39. Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being. (Abstract)

Probiotic treatment for women with gestational diabetes to improve maternal and infant health and well-being. Gestational diabetes mellitus (GDM) is carbohydrate intolerance first recognised during pregnancy and associated with complications for mothers and babies. Probiotics are naturally occurring micro-organisms, which when ingested in adequate amounts, may confer health benefits. Evidence of the role of probiotics as treatment for GDM is limited.To evaluate the safety and effectiveness (...) risk of bias of included trials. The certainty of evidence for selected maternal and infant/child outcomes was assessed using GRADE.Nine RCTs (695 pregnant women with GDM) comparing probiotics versus placebo were identified. The overall risk of bias in the nine RCTs was low to unclear and the evidence was downgraded for imprecision due to the small numbers of women participating in the trials. The trials were carried out in hospitals and universities in Iran (seven trials), Thailand (one trial

2020 Cochrane

40. Higher versus lower protein intake in formula-fed low birth weight infants. (Abstract)

Higher versus lower protein intake in formula-fed low birth weight infants. The ideal quantity of dietary protein for formula-fed low birth weight infants is still a matter of debate. Protein intake must be sufficient to achieve normal growth without leading to negative effects such as acidosis, uremia, and elevated levels of circulating amino acids.To determine whether higher (≥ 3.0 g/kg/d) versus lower (< 3.0 g/kg/d) protein intake during the initial hospital stay of formula-fed preterm (...) infants or low birth weight infants (< 2.5 kilograms) results in improved growth and neurodevelopmental outcomes without evidence of short- or long-term morbidity. Specific objectives were to examine the following comparisons of interventions and to conduct subgroup analyses if possible. 1. Low protein intake if the amount was less than 3.0 g/kg/d. 2. High protein intake if the amount was equal to or greater than 3.0 g/kg/d but less than 4.0 g/kg/d. 3. Very high protein intake if the amount was equal

2020 Cochrane